GOLDMAN SACHS & Co. LLC 200 West Street New York, New York 10282 |
BOFA SECURITIES, INC. 1111 Avenue of the Americas New York, New York 10036 |
JEFFERIES LLC 520 Madison Avenue New York, New York 10022 |
October 25, 2021
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
Attn: | Ms. Lauren Hamill |
Ms. Christine Wong
Ms. Mary Mast
Ms. Celeste Murphy
Re: | LianBio |
Registration Statement on Form S-1
File No. 333-259978
Acceleration Request | ||
Requested Date: |
Wednesday, October 27, 2021 | |
Requested Time: |
4:00 P.M. Eastern Daylight Time |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned hereby join in the request of LianBio, an exempted company organized under the Laws of the Cayman Islands (the Registrant), that the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-259978) (the Registration Statement) be accelerated so as to permit it to become effective on October 27, 2021, at 4:00 p.m., Eastern Daylight Time, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff (the Staff).
Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that as of the date hereof, 2,766 copies of the Preliminary Prospectus dated October 20, 2021 have been distributed to prospective underwriters and dealers, institutional investors, retail investors and others.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours, | ||
GOLDMAN SACHS & CO. LLC | ||
By: | /s/ Dan Cocks | |
Name: Dan Cocks | ||
Title: Managing Director | ||
BOFA SECURITIES, INC. | ||
By: | /s/ Greg Butz | |
Name: Greg Butz | ||
Title: Managing Director | ||
JEFFERIES LLC | ||
By: | /s/ Matthew Kim | |
Name: Matthew Kim | ||
Title: Managing Director, Joint US Head of Biotechnology |
[Signature Page to Acceleration Request]